Biota Pharmaceuticals CEO Andrei Floroiu's 2023 pay falls 48% to $1.9M
Biota Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Biota Pharmaceuticals reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at Biota Pharmaceuticals received on average a compensation package of $1.4M, a 44% decrease compared to previous year.
Average pay of disclosed executives at Biota Pharmaceuticals
Andrei Floroiu, Chief Executive Officer, received $1.9M in total, which decreased by 48% compared to 2022. 43% of Floroiu's compensation, or $802K, was in option awards. Floroiu also received $199K in non-equity incentive plan, $568K in salary, $287K in stock awards, as well as $11K in other compensation.
James Cummings, Chief Medical Officer, received a compensation package of $1.2M, which decreased by 39% compared to previous year. 39% of the compensation package, or $455K, was in salary.
Sean N. Tucker, Chief Scientific Officer, earned $1.1M in 2023, a 40% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.